Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 10/20 | 0.56 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.56 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.50 |
| ▸ | NOS2 | P35228 | 2/20 | 0.47 |
| ▸ | NOS3 | P29474 | 2/20 | 0.47 |
| ▸ | NOS1 | P29475 | 2/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.45 |
| ▸ | GRM8 | O00222 | 1/20 | 0.45 |
| ▸ | GRM6 | O15303 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.45 |
| ▸ | GSR | P00390 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.45 |
| ▸ | GRM5 | P41594 | 1/20 | 0.45 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.45 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.45 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Racemethionine SCHEMBL27265226 | 1.00 | BHMT (0.56) | BHMTBHMT2RNPEPNOS2NOS3 | |
| Methionine SCHEMBL14485913 | 1.00 | BHMT (0.56) | BHMTBHMT2RNPEPNOS2NOS3 | |
| Methionine SCHEMBL1163783 | 1.00 | BHMT (0.56) | BHMTBHMT2RNPEPNOS2NOS3 | |
| Racemethionine SCHEMBL27264983 | 1.00 | BHMT (0.56) | BHMTBHMT2RNPEPNOS2NOS3 | |
| Racemethionine SCHEMBL1163782 | 1.00 | BHMT (0.56) | BHMTBHMT2RNPEPNOS2NOS3 | |
| Racemethionine SCHEMBL2804076 | 1.00 | BHMT (0.56) | BHMTBHMT2RNPEPNOS2NOS3 | |
| Methionine SCHEMBL15323126 | 0.94 | BHMT (0.51) | BHMTBHMT2RNPEPNOS2NOS3 | |
| Racemethionine SCHEMBL23361954 | 0.94 | BHMT (0.57) | BHMTBHMT2RNPEPNOS2NOS3 | |
| Racemethionine SCHEMBL8983115 | 0.94 | BHMT (0.57) | BHMTBHMT2RNPEPNOS2NOS3 | |
| Racemethionine SCHEMBL126688 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117441021-A | Methods and compositions for altering protein accumulation | 孟山都技术有限公司 | 2024-01-23 | — | — | CN | claimed |
| US-20210324027-A1 | MODIFIED INTERLEUKIN-7 PROTEINS AND USES THEREOF | GENEXINE, INC. (KR) | 2021-10-21 | — | — | US | claimed |
| CN-106834262-B | A kind of linoleate isomerase mutant and its application | 杭州师范大学 | 2019-08-16 | — | — | CN | claimed |
| CN-106834262-A | A kind of linoleate isomerase mutant and its application | 杭州师范大学 | 2017-06-13 | — | — | CN | claimed |
| US-8173871-B2 | Bacterial proteins with pesticidal activity | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2012-05-08 | — | — | US | claimed |
| EP-1642910-B1 | Rationally designed antibodies | ALEXION PHARMA INC (US) | 2012-02-08 | — | — | EP | claimed |
| US-20110020437-A1 | OLIGOPEPTIDIC COMPOUNDS AND USES THEREOF | APIM THERAPEUTICS AS (NO) | 2011-01-27 | — | — | US | claimed |
| US-7482435-B2 | Immunoglobulin for use in human therapeutics and diagnostics | ALEXION PHARMACEUTICALS, INC. (US) | 2009-01-27 | — | — | US | claimed |
| EP-1589034-B1 | Rationally designed antibodies | ALEXION PHARMA INC (US) | 2008-11-19 | — | — | EP | claimed |
| EP-1199355-B1 | SULFUR ATOM-FREE ENZYME PROTEINS | NAT INST OF ADVANCED IND SCIEN (JP) | 2007-03-14 | — | — | EP | claimed |
| US-6100070-A | HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR RECEPTOR AGONIST POLYPEPTIDE HAVING A MODIFIED AMINO ACID SEQUENCE; FOR STIMULATION OF BONE MARROW AND BLOOD CELL ACTIVATION AND GROWTH BEFORE THE EXPANDED CELLS ARE INFUSED INTO PATIENTS | G. D. SEARLE & CO. (US) | 2000-08-08 | — | — | US | claimed |
| US-6093395-A | HUMAN INTERLEUKIN-3 VARIANT OR MUTANT PROTEINS FUNCTIONALLY CO-ADMINISTERED WITH OTHER COLONY STIMULATING FACTORS, CYTOKINES, LYMPHOKINES, INTERLEUKINS, HEMATOPOIETIC GROWTH FACTORS OR INTERLEUKIN-3 VARIANTS | G. D. SEARLE & CO. (US) | 2000-07-25 | — | — | US | claimed |
| US-6060047-A | Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production | G. D. SEARLE & CO. (US) | 2000-05-09 | — | — | US | claimed |
| EP-0990156-A1 | CYCLIC PEPTIDE LIBRARIES AND METHODS OF USE THEREOF TO IDENTIFY BINDING MOTIFS | Beth Israel Deaconess Medical Center (US) | 2000-04-05 | — | — | EP | claimed |
| US-6017523-A | TREATING A IMMUNODEFICIENCY, HEMATOPOIETIC OR BONE MARROW DISORDER ;STIMULANTS; ANTICARCINOGENIC AGENTS; SIDE EFFECT REDUCTION; MUTEINS HAVING SEVERAL VARIATIONS, PREFERABLY IN ONE TO THREE AMINO ACIDS | G.D. SEARLE & CO. (US) | 2000-01-25 | — | — | US | claimed |
| US-5997857-A | COADMINISTERING WITH CSF, CYTOKINES, LYMPHOKINES, INTERLEUKINS, HEMATOPOIETIC GROWTH FACTORS OR IL-3 VARIANTS. | G. D. SEARLE & CO. (US) | 1999-12-07 | — | — | US | claimed |
| US-5997860-A | Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines | G. D. SEARLE & CO. (US) | 1999-12-07 | — | — | US | claimed |
| WO-1998054577-A9 | CYCLIC PEPTIDE LIBRARIES AND METHODS OF USE THEREOF TO IDENTIFY BINDING MOTIFS | BETH ISRAEL HOSPITAL (US) | 1999-04-01 | — | — | WO | claimed |
| US-5849875-A | Human tissue factor inhibitor | G. D. SEARLE & CO. (US) | 1998-12-15 | — | — | US | claimed |
| WO-1998054577-A1 | CYCLIC PEPTIDE LIBRARIES AND METHODS OF USE THEREOF TO IDENTIFY BINDING MOTIFS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 1998-12-03 | — | — | WO | claimed |